Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | MDT | MEDTRONIC PLC | Healthcare | 145,000.0 | $11.3M | 1.07% | +55K | +61.1% | $78.23 | +18.0% |
| 42 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 416,371.0 | $11.2M | 1.06% | +153K | +58.3% | $26.98 | -4.6% |
| 43 | OSCR | OSCAR HEALTH INC | Healthcare | 392,000.0 | $11.2M | 1.05% | -268K | -40.6% | $28.52 | +10.7% |
| 44 | RPRX | ROYALTY PHARMA PLC | Healthcare | 197,000.0 | $11.0M | 1.04% | -36K | -15.4% | $56.07 | +8.0% |
| 45 | DXCM | DEXCOM INC | Healthcare | 160,000.0 | $10.8M | 1.02% | NEW | — | $67.35 | +34.0% |
| 46 | ALGN | ALIGN TECHNOLOGY INC | Healthcare | 63,000.0 | $10.6M | 1.00% | +56K | +740.0% | $168.66 | -5.8% |
| 47 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 119,300.0 | $10.6M | 1.00% | NEW | — | $88.78 | +21.4% |
| 48 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 566,000.0 | $10.6M | 1.00% | +206K | +57.2% | $18.71 | +5.3% |
| 49 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 128,000.0 | $10.4M | 0.98% | -16K | -11.4% | $81.51 | +7.3% |
| 50 | A | AGILENT TECHNOLOGIES INC | Healthcare | 75,000.0 | $10.0M | 0.94% | +50K | +200.0% | $132.83 | +17.7% |
| 51 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 141,250.0 | $9.9M | 0.93% | +82K | +139.4% | $69.81 | +6.8% |
| 52 | ALKS | ALKERMES PLC | Healthcare | 185,250.0 | $9.7M | 0.92% | +52K | +39.0% | $52.40 | -8.4% |
| 53 | ABT | ABBOTT LABORATORIES | Healthcare | 96,000.0 | $8.7M | 0.82% | -16K | -14.3% | $90.74 | +25.9% |
| 54 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 86,127.0 | $8.4M | 0.79% | +4K | +5.5% | $97.48 | +12.3% |
| 55 | PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | 345,000.0 | $7.8M | 0.73% | -130K | -27.4% | $22.58 | -8.2% |
| 56 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 145,100.0 | $7.8M | 0.73% | +17K | +13.3% | $53.67 | -5.9% |
| 57 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 80,000.0 | $7.6M | 0.72% | NEW | — | $95.17 | +10.2% |
| 58 | EHC | ENCOMPASS HEALTH CORP | Healthcare | 74,263.0 | $7.5M | 0.71% | +18K | +32.0% | $101.08 | +19.6% |
| 59 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 384,800.0 | $7.5M | 0.71% | +145K | +60.7% | $19.47 | -18.5% |
| 60 | IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | 1,705,327.0 | $7.1M | 0.67% | -350K | -17.0% | $4.16 | +116.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.4%